AN2 Therapeutics
Stock Forecast, Prediction & Price Target

AN2 Therapeutics Financial Estimates

AN2 Therapeutics Revenue Estimates

AN2 Therapeutics EBITDA Estimates

AN2 Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $33.2M
Low: $33.2M
High: $33.2M
avg. 0%
Avg: $27.77M
Low: $27.77M
High: $27.77M
avg. -16.34%
Avg: $248.7M
Low: $248.7M
High: $248.7M
avg. 795.40%
Avg: $566.35M
Low: $566.35M
High: $566.35M
avg. 127.72%
Net Income
 
% change YoY
$-21.47M
 
N/A
$-41.47M
 
-93.11%
$-64.73M
 
-56.09%
Avg: $-91.53M
Low: $-64.19M
High: $-40.35M
avg. -41.40%
Avg: $-45.5M
Low: $-31.86M
High: $-6.37M
avg. 50.29%
Avg: $95.34M
Low: $95.34M
High: $95.34M
avg. 309.54%
Avg: $269.39M
Low: $269.39M
High: $269.39M
avg. 182.54%
EBITDA
 
% change YoY
$-21.57M
 
N/A
$-42.26M
 
-95.89%
$4.90M
 
111.60%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$1.15
 
N/A
-$2.14
 
-86.08%
-$2.74
 
-28.03%
Avg: -$2.38
Low: -$2.72
High: -$1.71
avg. 13.22%
Avg: -$0.71
Low: -$1.35
High: -$0.27
avg. 70.27%
Avg: $4.04
Low: $4.04
High: $4.04
avg. 671.69%
Avg: $11.42
Low: $11.42
High: $11.42
avg. 182.54%
Operating Expenses
 
% change YoY
$21.57M
 
N/A
$42.26M
 
95.89%
$69.63M
 
64.76%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is AN2 Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 125.24% in 2025-2028.

We have gathered data from 3 analysts. Their low estimate is -64.19M, average is -91.53M and high is -40.35M.

What is AN2 Therapeutics stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 226.69% in 2025-2028.

We have gathered data from 5 analysts. Their low revenue estimate is $33.2M, average is $33.2M and high is $33.2M.

What is AN2 Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 234.43% in 2025-2028.

We have gathered data from 3 analysts. Their low earnings per share estimate is -$2.72, average is -$2.38 and high is $-1.71.

What is the best performing analyst?

In the last twelve months analysts have been covering AN2 Therapeutics stock. The most successful analyst is Joseph Schwartz.